menu
    • menu
    [{"orgOrder":0,"company":"Contera Pharma","sponsor":"Bukwang Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"DENMARK","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"JM-010","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Contera Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Contera Pharma \/ Bukwang Pharmaceutical","highestDevelopmentStatusID":"8","companyTruncated":"Contera Pharma \/ Bukwang Pharmaceutical"},{"orgOrder":0,"company":"Contera Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"DENMARK","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"JM-010","moa":"Undisclosed","graph1":"Neurology","graph2":"Phase II","graph3":"Contera Pharma","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Contera Pharma \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"Contera Pharma \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by Contera Pharma

    Menu

    Contera Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Contera Pharma

                            Denmark arrow
                            OTS 2025
                            Not Confirmed

                            Contera Pharma

                            Denmark arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : JM-010

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Open-Label Extension Study of ASTORIA

                            Details : JM-010 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dyskinesias.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            August 26, 2022

                            Lead Product(s) : JM-010

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Contera Pharma

                            Denmark arrow
                            OTS 2025
                            Not Confirmed

                            Contera Pharma

                            Denmark arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : JM-010

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Bukwang Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia

                            Details : JM-010 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dyskinesias.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            May 21, 2019

                            Lead Product(s) : JM-010

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Bukwang Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth